:   [Ÿ ̺] 簡 ϴ Ÿ D ̾߱...ѹα Ÿ D
ŭ ȿɵ پ Ÿ'. 츮 Ÿο ؼ 󸶳 ˰ ? ̴ ذ(߾Ӿ౹) ̴ Բ ٻ ε Ÿ ̵带 óѴ. ̴ Ÿκ(VITAMIN+BIBLE) Բ Ÿο ڼ ˾ƺ.



Ÿ D 뼺 Ÿ , ޺ ظ ڿܼ(UV) ؼ 츮 ڿ ռȴ. ׷̵ ȣ ȣ ۿϿ, ſ ð پ Ÿ D ȣ Ѵ. Ÿ D 5 (D1~D5) ִ. Ÿ D2 D3. Ÿ D2 'Į(Ergocalciferol; D2)' Ĺ շ ַ ߰ߵǰ Ÿ D3 'ݷĮ(Cholecalciferol; D3)' ַ  ⸧ ߰ߵȴ. ݷĮѰ Į 1:1 ȥչ Ÿ D1 зϱ⵵ Ѵ. ü ռǴ Ÿ D Ÿ D3̴.

Ÿ D ó: Ƽ̹ ũ



ó Ÿ D ҰǾ ܼϰ Į 縦 Ѵٰ ˷. , ü پ Ÿ D ü(VDR, Vitamin D receptor) Ѵٴ ߰ߵǾ, Ÿ D ִ پ ð Ǿ. Ÿ D ݱ١̳ 硯, 塯, 鿪ɡ, ġ پ ü ɰ õǾ ִٴ ְ ƴ.

Ӹ ƴ϶ ٸ ҿ Բ ū ȿ Ѵٴ ǵ ߰ߵǰ ִ. ǥ Į Ÿ D ִ. Ҹ Ͽ , е ȿ 󿹹濡 ȿ̶ ִ.̿ܿ Ÿ D ִ ȯ ߺ ɷ¿ Ǹ鼭, ߿伺 εǰ ִ. ֱ Ÿ D ߻ ҽŰ, ϴ ȣ , ϰ Ϻ ߻ ִ.



Ÿ D ռ



ŸD ȯ ó: Vitamin D as A Protector of Arterial Health: Potential Role in Peripheral Arterial Disease Formation by Dr Smriti M Krishna

Ǻ ݷ׷ 繰 ϳ 7-̵ݷ׷(7-dehydrocholesterol, Pro-Vitamin D3) Ѵ. ޺ ڿܼ ް Ǹ Pro-Vitamin D3 Ÿ D3 ȯȴ. ڿܼ ߿ ڿܼ B(UVB) Ÿ D ռ ߿ ϰ Ǵµ, UVB â ޺ ޾ƾ߸ Ÿ D Ȱϰ ռȴ.

Ǻο ռ Ÿ D3 縦 Įô̿(Calcidiol) ǰ, 忡 縦 ģ ĮƮ(Calcitriol)̶ ŸD · ȯȴ. ̳ ȿ շ ׷(Ergosterol) · ϴµ, ڿܼ Ÿ D2 ȯǾ Ŀ Įô̿á, ĮƮá ȯ ´. ĮƮ ǥ θ ۿϴµ ϳ ü ۿ(Non-genomic action) - Į(Voltage-dependent calcium channels) Ȱȭϴ ̰, ٸ ϳ Ÿ D ü(VDR, Vitamin D receptor) ν ü ۿ(Genomic action) ϴ ̴.



Ÿ D

ѱ û ŸD ġ(20082014  ǰ )ó: ϼ



Ÿ D(Įô̿) 󵵿 Ǵ . ׷, κ 10 ng/mL ̸ (Severe deficiency), 10~20 ng/mL (Deficiency), 21~29 ng/mL (Relative insufficiency), 30 ng/mL ̻ (Sufficiency) ϰ ִ.Ÿ D ü پ ɰ ֱ , Ÿ D ڿ ȯ õȴ. Ÿ D ϸ 忡 Į 忡 Į ϸ鼭 û Į 󵵰 , Į 󵵰 ̸ ϱ ΰȣ к ȴ. ΰ ʷϸ, İ ȰȭϿ ȸȭ κ Į Ű, Һ λ輳 Ų. , λ󵵰 Į- ϰ ǰ ȸȭ صǾ Ҿƿ 纴, ο ȭ ϰ ȴ. , Ÿ D ν к ǥ ν ü 谡 ־ 索 ߿ Ѵ. Ҿ, 鿪ۿ뿡 Ͽ ڰ鿪ȯ ū ָ ֱ͵ ־ İ 濡 ʼ̴. Ÿ D ũ ε巯 ִٴ ̴. ̱ ΰǰ(National Health and Nutrition Examination Survey) , 2001~2004⵵ ̱ Ÿ D 󵵴 24 ng/mL 1988~1994⵵ 6 ng/mL ߴ. ü ̱ 23% Ÿ D 30 ng/mL ̻ Ѵٴ ǹߴ. ̿ܿ پ ȣƮ ̱ 52~77% Ÿ D Ǵ ̿ شȴٴ ߰ߴ. 츮 ٸ ʴ. ٰ Ÿ D ġ , Ÿ D ġ 30 ng/mL ̸ Ÿ Ÿ D ش 92% Ǿ, 12 ng/mL ̸ 쵵 57% Ǿ. ⼭ ġ ʴ´. 翡 Ÿ D ȭǰ ִ. 20 ¸ 84.2% Ÿ D Ÿ. Ÿ D ߴµ, 88.6% Ÿ D 巯 (79.4%) ̷ . ǰ 5 ڷῡ , ѱ Ÿ D ġ ų ̴. ̷ Ÿ D Ȱ ȭ ãƺ ִ. Ÿ D ڿܼ B Ǻο ڿ Ǵµ 뿡  ܺ Ȱٴ ַ dz Ȱϱ , Ÿ D ް Ǵ ̴. Ÿ D ȭǴ dz Ȱ ڿܼ ޵ ְ, ε . 츮 35 ̻ ġϰ ־ ޺θ Ÿ D ռϱ⿡ ڿܼ ϸ, 11~3 ڿܼ ŸD ռ .



Ÿ D ù

Ÿ پ ڿ ռδ Ÿ D ʿ䷮ ä . , ڿܼ 1 ߾Ϲ̱⿡ ǰ ؼ ϴ Ѵ. Ÿ D ڿܼ̳ ޺ ȿ 'ũ P450 Ÿ D-25-ȭȿ(25-hydroxylase, CYP2R1)' ȭǾ 25(OH) D ȯȴ. 25(OH) D ׿ £ 󵵷 ϴ Ÿ D̸, Ÿ D ¸ ݿϴ ߿ ǥ ȴ.



Ϲ ǰ Ƕ̵ó: Harvard T.H. Chan School of Public Health



׷, Ǻο ѱȸ 2020 ѱ ء ѱ Ĵܿ Ÿ D dz ڿǰ . , 븸 Ÿ D ϱⰡ ƴ. Ϲ T.H. æ Ǵп(Harvard T.H. Chan School of Public Health) ̵ ǰ Ƕ̵带 ڿ ռ̳ 븸 Ÿ D ϸ, ߰ ϰ ִ. ׷⿡ Ÿ D ϴ δ ̶ δ. 츮 ϴ Ÿ D δ Ÿ D2ٴ Ÿ D3(ݷĮ) ϴ . Ÿ D3 Ÿ D2 ϴ ͺ Ÿ D ߳󵵰 1.7 , µ 󵵵 Ǿ. ̴ Ÿ D3 ݰⰡ 3ַ, ݰⰡ 2 Ÿ D2 ̸ Įô̿÷ ȯ ִ 'ũ P450 Ÿ D-25-ȭȿ' Ȱ D3 ũ ̴. Ÿ D3 κ ̶ ⸧п Ѵ.  ڿ÷ Ǿ ִµ, ݷ׷ ڿܼ  Ÿ D3 ռѴ. , D3 ۿ . ľó ѹα Ÿ D Ϸ 差 400IUε, D3 Ѵٸ 100谡 Ѵ 50,000IU 6ְ ص Ÿ ʴ´. Ϲ 1,000IU 3 ؾ ŸD ߳󵵰 10 ng/ml Ѵٰ ˷ ִ. ׷⿡ Ÿ D ϴٸ, ŸD ּ 差 30 ng/ml ̻ 󵵸 ϱ ؼ ׺ Ÿ D 밡 ʿϴ. ̿ ߸ ̱ Ÿ D 差 ÷ Ѵٰ ϰ ִ. Ÿ D ǰ Ŭ Ȧ ڻ(Michael F. Holick) Ÿ D ġ 40 ng/mL~60 ng/mL Ѵٸ ü Ƿ 25% ̶ ߴ.



= ̴ ذ (߾Ӿ౹)

: ؼҿ vs
: ö ࡯, ȯ ǻ?